Carcinoma Breast Stage IV Clinical Trial
Official title:
A Phase II Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Locally Advanced or Metastatic Breast Cancer
This is a phase II, multicenter, single-arm, open-label safety and efficacy study of bavituximab in combination with carboplatin plus paclitaxel in patients with locally advanced or metastatic breast cancer.
n/a
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03511781 -
Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer
|
N/A | |
| Completed |
NCT00199212 -
PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2
|
Phase 1 | |
| Recruiting |
NCT06281860 -
Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration
|
Phase 1 | |
| Active, not recruiting |
NCT02755272 -
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
|
Phase 2 | |
| Withdrawn |
NCT02140437 -
Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC
|
Phase 2 | |
| Terminated |
NCT02183805 -
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer
|
Phase 2 | |
| Terminated |
NCT01531764 -
BIBW 2992 (Afatinib) and Vinorelbine
|
Phase 2 | |
| Completed |
NCT01631552 -
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT01906112 -
Role of Surgery for the Primary in Patients With Breast Cancer Stage IV.
|
Phase 3 | |
| Recruiting |
NCT02161315 -
Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer
|
N/A | |
| Completed |
NCT00433095 -
Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer
|
Phase 2 |